Scott Morris Applications Engineering Manager BioVigilant Systems, Inc. BioVigilants Comprehensive Approach
Rapid Micro Methods Validation
Equipment
Testing of an RMM often requires specialized equipment and state of theart facilities; these components should be calibrated and thoroughly characterized for a rigorous assessment. Multimillion dollar purposebuilt bio test facility and automated aerosol test chamber Please refer to PDA Poster entitled, Development and Validation of a Test Chamber by Shinsuke Yamasaki, Azbil Corporation
IMD-A 300 (2) Alternate Methods IMD-A 350 (2) SAS, SMA, MAS Reference Methods Kanomax LSAPC
People
Equipment
Statistics
Test Chamber
The goal of the analysis and nal data should be to distill the value of the other ve validation components to clearly demonstrate whether equivalence or better was achieved and deliver meaningful and relevant data to the end user.
USP<1223> is the benchmark guidance for RMM validation, but other relevant guidance documents should be considered and harmonized for a comprehensive validation:
Part 11 21CFR TR33 RMM JIS 9921 21501 3836 ISO USP EP 13485 14644 1223
Bacillus atrophaeus
1000.00
5.1.6
To e ectively apply a Rapid Microbial Method (RMM) technique and leverage its value, the end user must match his or her application and requirements to the bene ts and performance of the RMM. Understanding the general approach to validation as well as the inter-relationships between personnel and their quali cations, guidance and regulations, statistics employed, test equipment, test protocols, and data analysis techniques enhances this evaluation. Through this holistic understanding, more robust dialogue can be fostered, and ultimately, a more successful adoption of an RMM technology may be realized.
100.00
10.00
1.00
0.10 T1 T2 T3 T4 T5
Concentration
IMD-A 300 (#1) IMD-A 300 (#2) IMD-A 350 (#1) IMD-A 350 (#2) SAS MAS SMA
The graph to the left summarizes aerosol chamber results for a Bacillus atrophaeus microbe across ve concentrations. It clearly demonstrates not only the capability of the chamber to produce repeatable and homogeneous results, but it illustrates how the IMD-A systems yield repeatably higher recoveries than the reference methods
Statistics
Unique procedures for RMM testing are often integral to success, but they should build upon best practices, ensure traceability, and be formalized:
Microbes (ATCC strain #) Bacillus atrophaeus (9372) Corynebacterium afermentans (51403) Escherichia coli (13706) Staphylococcus epidermidis (12228) Micrococcus lylae (27566) Aspergillus niger (9142)
A comprehensive statistical architecture should be created to provide meaningful analysis, and also be detailed and formalized to ensure a repeatable and unbiased approach.
9 8 6
5 12
By the Numbers: > 4*108 Microbes aerosolized 2880 Individual samples collected > 1100 Agar plates manually counted 1460 USP<1223> evaluation
34 Tears cried
Validation of an RMM is not something that merely can be claimed; it must be demonstrated.
To help achieve these goals BioVigilant researched and employed the use of some unique statistical tools and methods:
Visit BioVigilants Booth 14 to obtain your copy of IMDA USP<1223> Test Results.
Alternative Acceptance Binomial Test Independent Linearity Reference Criteria Precision Transform